Cerebral microbleeds in early Alzheimer’s disease

Journal of Neurology

Volumn 263, Issue 10, 2016, Pages 1961-1968

  Poliakova, T ^a,b   Levin, O ^a   Arablinskiy, A ^b   Vasenina, E ^a   Zerr, I ^c  

^a Russian Medical Academy of Postgraduate Education   (Russian Federation)

^b SP Botkin City Hospital   (Russian Federation)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Alzheimer disease; Blood brain barrier damage; Cerebral microbleeds; Magnetic resonance imaging; Mild cognitive impairment; White matter lesions

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; TAU PROTEIN; AMYLOID BETA-PROTEIN (11-42); PEPTIDE FRAGMENT;

ADDENBROOKE COGNITIVE EXAMINATION; ADULT; AGED; ALBUMIN BLOOD LEVEL; ALZHEIMER DISEASE; AMNESIA; ARTICLE; ASSESSMENT OF HUMANS; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN CORTEX; BRAIN HEMORRHAGE; CAMBRIDGE COGNITIVE EXAMINATION BATTERY; CEREBROSPINAL FLUID; CEREBROVASCULAR DISEASE; CLOCK DRAWING TEST; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENOTYPE; GERMANY; HUMAN; LACUNAR STROKE; MAGNETIC FIELD; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MULTICENTER STUDY; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTPATIENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RUSSIAN FEDERATION; VERBAL FLUENCY TEST; VERBAL MEMORY TEST; VERY ELDERLY; VISUAL MEMORY; VISUAL MEMORY TEST; VISUAL PERCEPTION TEST; CEREBRAL HEMORRHAGE; COMPLICATION; DIAGNOSTIC IMAGING; GENETICS; IMAGE PROCESSING; MENTAL HEALTH;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 84978035447     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-016-8220-2     Document Type: Article

References (38)

1. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183–194
2. Cui Y, Liu B, Luo S, Zhen X, Fan M, Liu T, Zhu W, Park M, Jiang T, Jin JS (2011) Identification of conversion from mild cognitive impairment to Alzheimer’s disease using multivariate predictors. PLoS One 6:e21896
3. Haldenwanger A, Eling P, Kastrup A, Hildebrandt H (2010) Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non-amnesic MCI, and Alzheimer’s disease. J Alzheimers Dis 22:971–980
4. Hu WT, Chen-Plotkin A, Arnod SE, Grossman M, Shaw L, McCluskey L, Elman L, Hurtig H, Siderowf A, Lee VM, Soares H, Trojanowski JQ (2010) Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment. Acta Neuropathol 119:669–678
5. Mitchell AJ, Monge-Argilés JA, Sánchez-Paya J (2010) Do CSF biomarkers help clinicians predict the progression of mild cognitive impairment to dementia? Pract Neurol 10:202–207
6. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, Breteler MM (2009) Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 8:165–174
7. Cheng AL, Batool S, McCreary CR, Lauzon ML, Frayne R, Goyal M, Smith EE (2013) Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke 44:2782–2786
8. Schrag M, Greer DM (2014) Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging. J Stroke Cerebrovasc Dis 23:2489–2497
9. Yates PA, Villemagne VL, Ellis KA, Desmond PM, Masters CL, Rowe CC (2014) Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Front Neurol 4:205
10. Fang M, Feng C, Xu Y, Hua T, Jin AP, Liu XY (2013) Microbleeds and silent brain infarctions are differently associated with cognitive dysfunction in patients with advanced periventricular leukoaraiosis. Int J Med Sci 10:1307–1313
11. Van der Flier WM, Cordonnier C (2012) Microbleeds in vascular dementia: clinical aspects. Exp Gerontol 47:853–857
12. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, De Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, van Oostenbrugge R, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M, v1 SfRVconS, (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lanc Neurol 12:822–838
13. Zhang M, Chen M, Wang Q, Yun W, Zhang Z, Yin Q, Huang Q, Zhu W (2013) Relationship between cerebral microbleeds and cognitive function in lacunar infarct. J Int Med Res 41:347–355
14. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L (2006) Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5:228–234
15. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078–1085
16. Gregoire SM, Chaudhary UJ, Brown M, Yousry TA, Kallis C, Jäger HR, Werring D (2009) The Microbleed Anatomocal Rating Scale (MARS):reliability of a tool to map brain microbleeds. Neurology 73:1759–1766
17. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, Changes ETFoA-RWM (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32:1318–1322
18. Scheltens P, Launer LJ, Barkhof F, Weinstein HC, Van Gool WA (1995) Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol 242:557–560
19. Schmidt C, Becker H, Zerr I (2014) Cerebrospinal fluid apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer’s disease. Am J Alzheimers Dis Other Demen 29:54–60
20. Karch A, Manthey H, Ponto C, Hermann P, Heinemann U, Schmidt C, Zerr I (2013) Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia. PLoS One 8:e84405
21. Goos JD, Kester MI, Barkhof F, Klein M, Blankenstein MA, Scheltens P, Van der Flier W (2009) Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke 40:3455–3460
22. Lei C, Lin S, Tao W, Hao Z, Liu M, Wu B (2013) Association between cerebral microbleeds and cognitive function: a systematic review. J Neurol Neurosurg Psychiatry 84:693–697
23. Wu R, Feng C, Zhao Y, Jin AP, Fang M, Liu X (2014) A meta-analysis of association between cerebral microbleeds and cognitive impairment. Med Sci Monit 20:2189–2198
24. Samtani M, Raghavan N, Shi Y, Novak G, Farnum M, Lobanov V, Schultz T, Yang E, DiBernardo A, Narayan VA, AsDN Initiative (2013) Disease progression model in subjects with mild cognitive impairment from the Alzheimer’s disease neuroimaging initiative: CSF biomarkers predict population subtypes. Br J Clin Pharmacol 75:146–161
25. Waragai M, Yoshida M, Mizoi M, Saiki R, Kashiwagi K, Takagi K, Arai H, Tashiro J, Hashimoto M, Iwai N, Uemura K, Igarashi K (2012) Increased protein-conjugated acrolein and amyloid -β40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis 32:33–41
26. Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O (2012) Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5–10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry 69:98–106
27. Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund-Levi Y, Tsolaki M, Minthon L, Wallin AK, Hampel H, Burger K, Pirttila T, Soininen H, Rikkert MO, Verbeek MM, Spiru L, Blennow K (2009) Prevalence and prognostic value of CSF markers of Alzheimer’s disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol 8:619–627
28. Forlenza OV, Diniz BS, Stella F, Teixeira AL, Gattaz WF (2013) Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia. Rev Bras Psiquitar 35:178–185
29. Parnetti L, Chiasserini D, Eusebi P, Giannandrea D, Bellomo G, De Carlo C, Padiglioni C, Mastrocola S, Lisetti V, Calabresi P (2012) Performance of Aβ1-40, Aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment. J Alzheimers Dis 29:229–238
30. Lim YY, Ellis KA, Harrington K, Pietrzak RH, Gale J, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P (2013) Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer’s disease? J Alzheimers Dis 33:1167–1176
31. Vieira RT, Caixeta L, Machado S, Silva AC, Nardi AE, Arias-Carrión O, Carta MG (2013) Epidemiology of early-onset dementia: a review of the literature. Clin Pract Epidemiol Ment Health 9:88–95
32. Charidimou A, Werring D (2014) A raging fire in acute lacunar stroke: inflammation, blood-brain barrier dysfunction and the origin of cerebral microbleeds. J Neurol Sci 34:1–2
33. Taheri S, Gasparovic C, Huisa BN, Adair JC, Edmonds E, Prestopnik J, Grossetete M, Shah NJ, Wills J, Qualls C, Rosenberg GA (2011) Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 42:2158–2163
34. Van Assema DM, Lubberrink M, Bauer M, van der Flier W, Schuit RC, Windhorst AD, Comans EF, Hoetjes NJ, Tolboom N, Langer O, Müller M, Scheltens P, Lammertsma AA, van Berckel BN (2012) No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer’s disease patients with microbleeds. J Cereb Blood Flow Metab 32:1468–1471
35. Wallin A, Blennow K, Fredman F (1990) Blood brain barrier function in vascular dementia. Acta Neurol Scand 81:318–322
36. Loehrer E, Ikram MA, Akoudad S, Vrooman HA, van der Lugt A, Niessen WJ, Hofman A, Vernooij MW (2014) Apolipoprotein E genotype influences spatial distribution of cerebral microbleeds. Neurobiol Aging 35:899–905
37. Maxwell SS, Jackson CA, Paternoster L, Cordonnier C, Thijs V, Al-Shahi Salman R, Sudlow CL (2011) Genetic associations with brain microbleeds: systematic review and meta-analyses. Neurology 77:158–167
38. Spampinato MV, Rumboldt Z, Hosker RJ, Mintzer JE, AsDN Initiative (2011) Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. Radiology 258:843–852